AB-03

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAB-03
Drug Alias NameS-14 (Araclon Biotech)AB-03
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors agonistsNeuroprotectantsPhosphodiesterase 7 inhibitors
TargetsDopamine receptorsPhosphodiesterase 7
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAraclon Biotech Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAraclon Biotech Sl
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A